Anuh Pharma reported audited FY26 net profit of ₹410.46 lakhs, a decrease from ₹473.52 lakhs in the previous year.
The Board recommended a final dividend of ₹1.50 per share (30%) for FY26, subject to shareholder approval.
A 1:1 bonus share issue was completed in July 2025, doubling the paid-up capital to ₹501.12 lakhs.
New Labour Code implementation resulted in a one-time provision of ₹48.31 lakhs for increased employee benefits.